Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History
Slate Path Capital LP
- $5.09 Billion
- Q2 2024
A detailed history of Slate Path Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Slate Path Capital LP holds 20,191,184 shares of TEVA stock, worth $353 Million. This represents 6.44% of its overall portfolio holdings.
Number of Shares
20,191,184
Previous 26,896,184
24.93%
Holding current value
$353 Million
Previous $380 Million
13.54%
% of portfolio
6.44%
Previous 7.63%
Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
617Shares Held
563MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$752 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$636 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$566 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$505 Million3.23% of portfolio
-
Exor Capital LLP London, X026.5MShares$463 Million15.49% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...